Mark Powell

2.2k total citations
52 papers, 1.7k citations indexed

About

Mark Powell is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Mark Powell has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Mark Powell's work include Esophageal Cancer Research and Treatment (7 papers), Cancer Genomics and Diagnostics (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Mark Powell is often cited by papers focused on Esophageal Cancer Research and Treatment (7 papers), Cancer Genomics and Diagnostics (7 papers) and Glycosylation and Glycoproteins Research (6 papers). Mark Powell collaborates with scholars based in United States, United Kingdom and Sweden. Mark Powell's co-authors include Sen‐itiroh Hakomori, K. Watanabe, Al B. Benson, Paul J. Catalano, Rafat Ansari, Weijing Sun, Peter J. O’Dwyer, Ten Feizi, Meredith M. Regan and Ross S. Berkowitz and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Annals of Internal Medicine.

In The Last Decade

Mark Powell

50 papers receiving 1.6k citations

Peers

Countries citing papers authored by Mark Powell

Since Specialization

Citations

This map shows the geographic impact of Mark Powell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Powell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Powell more than expected).

Fields of papers citing papers by Mark Powell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Powell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Powell. The network helps show where Mark Powell may publish in the future.

Co-authorship network of co-authors of Mark Powell

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Powell. A scholar is included among the top collaborators of Mark Powell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Powell. Mark Powell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Radiosynthesis and Evaluation of 11C-Labeled Isoindolone-Based Positive Allosteric Modulators for Positron Emission Tomography Imaging of Metabotropic Glutamate Receptor 2 2024 ·ACS Pharmacology & Translational Science ·Yinlong Li, Kenneth Dahl, Peter Johnström, Katarina Varnäs, Lars Farde, Christer Halldin, (unknown), Donna L. Maier, Mark Powell, Jiahui Chen, Richard Van, Jimmy S. Patel, (unknown), Yabiao Gao, Zhendong Song, Ahmed Haider, Yihan Shao, Charles S. Elmore, Steven H. Liang, Magnus Schou	0
2	Safety and efficacy of the tumor-selective adenovirus enadenotucirev, in combination with nivolumab, in patients with advanced/metastatic epithelial cancer: a phase I clinical trial (SPICE) 2023 ·Journal for ImmunoTherapy of Cancer ·Marwan Fakih, Wael A. Harb, Daruka Mahadevan, Hani M. Babiker, Jordan Berlin, Tom Lillie, David Krige, (unknown), Chris D. Cox, Minesh Patel, (unknown), Mark Powell, Lee S. Rosen	28
3	ARCTIC: durvalumab with or without tremelimumab as third-line or later treatment of metastatic non-small-cell lung cancer 2020 ·Annals of Oncology ·David Planchard, Niels Reinmuth, С. В. Орлов, Jürgen R. Fischer, Shunichi Sugawara, Sławomir Mańdziuk, Diego Márquez-Medina, Silvia Novello, Yuichiro Takeda, Ross A. Soo, K. Park, Michael McCleod, Sarayut Lucien Geater, Mark Powell, (unknown), Urban Scheuring, Paul K. Stockman, Dariusz M. Kowalski	118
4	P1.18-02 The AEGEAN Phase 3 Trial of Neoadjuvant/Adjuvant Durvalumab in Patients with Resectable Stage II/III NSCLC 2019 ·Journal of Thoracic Oncology ·John V. Heymach, Janis M. Taube, Tetsuya Mitsudomi, David Harpole, Mike Aperghis, Leonardo Trani, Mark Powell, Phillip A. Dennis, Martin Reck	20
5	Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group 2014 ·Investigational New Drugs ·Kristen K. Ciombor, Yang Feng, Al B. Benson, Yingjun Su, Linda W. Horton, Sarah P. Short, John Kauh, Charles A. Staley, Mary F. Mulcahy, Mark Powell, Katayoun I. Amiri, Ann Richmond, Jordan Berlin	23
6	Contribution of Artifacts to N-Methylated Piperazine Cyanide Adduct Formation In Vitro from N-Alkyl Piperazine Analogs 2013 ·Drug Metabolism and Disposition ·Minli Zhang, (unknown), Jian Guo, Mark Powell, Charles S. Elmore, Jun Hu, Karthick Vishwanathan	3
7	“Entering a clinical trial: Is it right for you?” 2011 ·Cancer ·Brianna Hoffner, Susan Bauer‐Wu, Suzanne Hitchcock‐Bryan, Mark Powell, (unknown), Steven Joffe	32
8	Genetic variation in radiation and platinum pathways predicts severe acute radiation toxicity in patients with esophageal adenocarcinoma treated with cisplatin-based preoperative radiochemotherapy: results from the Eastern Cooperative Oncology Group 2011 ·Cancer Chemotherapy and Pharmacology ·Harry H. Yoon, Paul J. Catalano, Michael K. Gibson, Todd C. Skaar, Santosh Philips, Elizabeth A. Montgomery, Michael J. Hafez, Mark Powell, Geoffrey Liu, Arlene A. Forastiere, Al B. Benson, Lawrence Kleinberg, Kathleen M. Murphy	9
9	Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group 2011 ·BMC Cancer ·Harry H. Yoon, Paul J. Catalano, Kathleen M. Murphy, Todd C. Skaar, Santosh Philips, Mark Powell, Elizabeth A. Montgomery, Michael J. Hafez, Steven M. Offer, Geoffrey Liu, Stephen J. Meltzer, Xifeng Wu, Arlene A. Forastiere, Al B. Benson, Lawrence Kleinberg, Michael K. Gibson	20
10	Prevalence and Predictors of Appropriate Colorectal Cancer Surveillance in Lynch Syndrome 2010 ·The American Journal of Gastroenterology ·Elena M. Stoffel, Rowena Mercado, Wendy Kohlmann, Beth Ford, Shilpa Grover, Peggy Conrad, Amie Blanco, Kristen M. Shannon, Mark Powell, Daniel C. Chung, Jonathan P. Terdiman, Stephen B. Gruber, Sapna Syngal	51
11	The Generation-Skipping Transfer Tax: A Quick Guide: Boil Down the Complexities to Avoid Costly Errors in Your Clients' Estate Plans 2009 ·Journal of accountancy online/Journal of accountancy ·Mark Powell	0
12	[N-methyl-3H3]AZ10419369 Binding to the 5-HT1B Receptor: In Vitro Characterization and in Vivo Receptor Occupancy 2009 ·Journal of Pharmacology and Experimental Therapeutics ·Donna L. Maier, (unknown), Min Ding, Mark Powell, Qiaoling Jiang, (unknown), J. Richard Heys, Charles S. Elmore, M. Edward Pierson, Ladislav Mrzljak	27
13	Enhancing Safety Reporting in Adult Ambulatory Oncology With a Clinician Champion 2009 ·Journal of Nursing Care Quality ·Saul N. Weingart, (unknown), (unknown), Maureen Connor, (unknown), (unknown), (unknown), Mark Powell, Patricia Reid Ponte, Barbara E. Bierer	10
14	Impact of Patient Age and Comorbidity on Surgeon Versus Oncologist Preferences for Adjuvant Chemotherapy for Stage III Colon Cancer 2008 ·Journal of the American College of Surgeons ·Monika K. Krzyzanowska, Meredith M. Regan, Mark Powell, Craig C. Earle, Jane C. Weeks	46
15	[11C]AZ10419369: A selective 5-HT1B receptor radioligand suitable for positron emission tomography (PET). Characterization in the primate brain 2008 ·NeuroImage ·M. Edward Pierson, Jan Andersson, Svante Nyberg, Dennis J. McCarthy, Sjoerd J. Finnema, Katarina Varnäs, Akihiro Takano, Per Karlsson, Balázs Gulyás, (unknown), Chi‐Ming Lee, Mark Powell, J. Richard Heys, W. M. Potts, Nicholas Seneca, Ladislav Mrzljak, Lars Farde, Christer Halldin	58
16	Sharing Genetic Test Results in Lynch Syndrome: Communication With Close and Distant Relatives 2008 ·Clinical Gastroenterology and Hepatology ·Elena M. Stoffel, Beth Ford, Rowena Mercado, (unknown), Wendy Kohlmann, Peggy Conrad, Amie Blanco, Kristen M. Shannon, Mark Powell, Stephen B. Gruber, Jonathan P. Terdiman, Daniel C. Chung, Sapna Syngal	92
17	Long‐term psychosocial adjustment of older vs younger survivors of breast and endometrial cancer 2007 ·Psycho-Oncology ·Alice B. Kornblith, Mark Powell, Meredith M. Regan, Samantha Bennett, Carolyn Krasner, Beverly Moy, Jerry Younger, (unknown), Ross S. Berkowitz, Eric P. Winer	175
18	Dynamic contrast enhanced magnetic resonance scanning as a predictor of response to accelerated radiotherapy for advanced head and neck cancer. 1999 ·British Journal of Radiology ·Peter Hoskin, M.I. Saunders, K. Goodchild, Mark Powell, N. Jane Taylor, H Baddeley	108
19	Surveillance after treatment for well differentiated thyroid cancer: Audit for chest radiography 1994 ·Clinical Oncology ·Mark Powell, E. Moskovic, Clive Harmer	10
20	Structural analysis of hexa- to octa-saccharide fractions isolated from sheep gastric-glycoproteins having blood-group I and i activities 1981 ·Carbohydrate Research ·Elizabeth F. Hounsell, (unknown), Ten Feizi, Minoru Fukuda, Mark Powell, Sen‐itiroh Hakomori	38

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact